By NEIL UNMACK
A friendly takeover deal for Allergan’s generic drugs unit is far easier than the hostile bid that Teva was pursuing for Mylan.
Published: July 28, 2015 at 12:00AM
Read more at: NYT Business Day
Subscribe
Login
0 Comments
Newest
- Related Content by Tag
- NYT